TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Double Bond Pharmaceutical International AB (publ)
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
707
|
920
|
831 |
| Financial expenses |
3,564
|
2,621
|
0 |
| Earnings before taxes |
-4,619
|
-11,645
|
-10,130 |
| EBITDA |
-938
|
-8,895
|
-10,002 |
| Total assets |
8,021
|
7,789
|
10,284 |
| Current assets |
3,638
|
3,370
|
4,342 |
| Current liabilities |
5,423
|
4,193
|
2,218 |
| Equity capital |
2,598
|
3,597
|
8,066 |
| - share capital |
3,478
|
3,203
|
2,114 |
| Employees (average) |
9
|
10
|
10 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
32.4%
|
46.2%
|
78.4% |
| Turnover per employee |
79
|
92
|
83 |
| Profit as a percentage of turnover |
-653.3%
|
-1265.8%
|
-1219.0% |
| Return on assets (ROA) |
-13.2%
|
-115.9%
|
-98.5% |
| Current ratio |
67.1%
|
80.4%
|
195.8% |
| Return on equity (ROE) |
-177.8%
|
-323.7%
|
-125.6% |
| Change turnover |
-182
|
85
|
192 |
| Change turnover % |
-21%
|
10%
|
30% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-10%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.